Is high-dose CBD harmful to your liver? In this Cannafyl Podcast, Ed Chaney and Kimberly Rose break down a recent FDA-funded study on liver enzymes and CBD use.
In this episode of The CBD Ed Show, Ed Chaney and Kimberly Rose explore a 2023 FDA-funded clinical trial that sparked questions about the safety of high-dose CBD isolate. The study involved 201 healthy adults taking 1,500mg of CBD daily for six weeks.
We share expert commentary from Dr. Bonnie Goldstein, who argues the study doesn’t reflect real-world CBD use. Learn the differences between CBD isolate vs full-spectrum, understand what elevated liver enzymes really mean, and find out what this study actually says about CBD safety.
Timestamps:
00:00 – Introduction to the CBD Study
01:00 – Study Overview & Relevance
02:00 – High-Dose CBD Design
04:00 – Cost of High-Dose CBD
05:30 – What Are Liver Enzymes (ALT & AST)?
07:00 – Study Findings on Liver Health
09:00 – Dr. Goldstein’s Critique
12:00 – Full-Spectrum vs. Isolate
16:00 – Real Consumer Takeaways
20:00 – Final Thoughts on CBD Safety
22:00 – Ask Us Your Questions!